Drug Name |
Terazosin hydrochloride |
Drug ID |
BADD_D02159 |
Description |
Terazosin is a quinazoline derivative alpha-1-selective adrenergic blocking agent indicated for benign prostatic hyperplasia and hypertension[FDA Label][A176831]. Terazosin blocks adrenaline's action on alpha-1 adrenergic receptors, causing relaxation of smooth muscle in blood vessels and the prostate[A176837]. |
Indications and Usage |
For the treatment of symptomatic BPH and mild to moderate hypertension. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
G04CA03 |
DrugBank ID |
DB01162
|
KEGG ID |
D00610
|
MeSH ID |
C041226
|
PubChem ID |
44383
|
TTD Drug ID |
D0P9RF
|
NDC Product Code |
59746-383; 67544-581; 50090-2371; 71610-510; 50090-2623; 67544-562; 42291-821; 24689-882; 63187-456; 55700-750; 59746-386; 42291-822; 53002-1250; 70518-0074; 67544-564; 49999-227; 71610-478; 50090-0657; 42291-820; 60760-316; 70518-3114; 50090-0659; 24689-855; 63629-2439; 70518-0342; 71610-546; 59746-385; 53002-1726; 59746-384; 50268-766; 66267-389; 68788-9815; 65372-1127; 71610-595; 68788-9817; 53002-1728; 50268-765; 67544-563; 65862-205; 63629-4525; 50090-1559; 63415-0116; 70518-1875; 53002-1727; 24689-961; 24689-792; 66267-325; 71610-503; 71610-594; 63629-5237; 68788-9816; 50268-767; 63187-620; 42291-823; 50268-764 |
Synonyms |
Terazosin | Adecur | Apo-Terazosin | Dysalfa | Hytrin | Flotrin | Hytrin BPH | Hytrine | Heitrin | Deflox | Magnurol | Novo-Terazosin | Nu-Terazosin | PMS-Terazosin | terazosin hydrochloride anhydrous | Sutif | Tazusin | Terazoflo | Terazosin AZU | Terazosin Hexal | Terazosin hydrochloride | terazosin, monohydrochloride, dihydrate | Terazosina Alter | Terazosina Kern | Terazosina Qualix | Zayasel | A 45975 | ratio-Terazosin |